Paul R. McGuirk
Director/Board Member at GARDINER HEALTHCARE ACQUISITIONS CORP.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Marc F. Pelletier | M | 53 |
Aeromics, Inc.
 Aeromics, Inc. BiotechnologyHealth Technology Aeromics, Inc. operates as a preclinical company that develops clinical candidate targeting a molecular water channel for the treatment of cerebral edema (brain swelling) in stroke. It offers AER-271, a drug candidate that blocks aquaporin-4 (AQP4), the molecular water channel found at the blood-brain barrier and controls of cerebral edema in models for ischemic stroke, cardiac arrest, and water toxicity and blocks edema in models of cardiac ischemia and transplant. The company was founded by Marc F. Pelletier and Walter F. Boron in 2008 and is headquartered in Cleveland, OH.
Gardiner Founder LLC
| 16 years |
| Albert Bourla | M | 62 | 31 years | |
| Frank Sciavolino | M | 83 |
Gardiner Founder LLC
| 39 years |
| Janelle Anderson | M | 51 |
Gardiner Founder LLC
| 3 years |
| Dave Jenkins | M | - |
Aeromics, Inc.
Aeromics, Inc. BiotechnologyHealth Technology Aeromics, Inc. operates as a preclinical company that develops clinical candidate targeting a molecular water channel for the treatment of cerebral edema (brain swelling) in stroke. It offers AER-271, a drug candidate that blocks aquaporin-4 (AQP4), the molecular water channel found at the blood-brain barrier and controls of cerebral edema in models for ischemic stroke, cardiac arrest, and water toxicity and blocks edema in models of cardiac ischemia and transplant. The company was founded by Marc F. Pelletier and Walter F. Boron in 2008 and is headquartered in Cleveland, OH.
Gardiner Founder LLC
| 5 years |
| Matthew Rossen | M | 47 | 13 years | |
| Douglas Lankler | M | 58 | 25 years | |
| James Linton | M | 61 | 3 years | |
| Sally Susman | F | 62 | 17 years | |
| Rady Johnson | M | 63 | 30 years | |
| Jeffrey P. Draime | M | 57 |
Aeromics, Inc.
Aeromics, Inc. BiotechnologyHealth Technology Aeromics, Inc. operates as a preclinical company that develops clinical candidate targeting a molecular water channel for the treatment of cerebral edema (brain swelling) in stroke. It offers AER-271, a drug candidate that blocks aquaporin-4 (AQP4), the molecular water channel found at the blood-brain barrier and controls of cerebral edema in models for ischemic stroke, cardiac arrest, and water toxicity and blocks edema in models of cardiac ischemia and transplant. The company was founded by Marc F. Pelletier and Walter F. Boron in 2008 and is headquartered in Cleveland, OH. | 7 years |
| Thomas Ryan | M | 46 | 3 years | |
| Suzanne Johnson | F | 66 | 17 years | |
| Payal Sahni Becher | F | - | 27 years | |
| John DeYoung | M | 61 | 33 years | |
| Mike McDermott | M | 58 | 21 years | |
| Markus Green | M | - | 18 years | |
| Thomas Hoxie | M | - | - | |
| Thomas Zindrick | M | 65 |
Aeromics, Inc.
Aeromics, Inc. BiotechnologyHealth Technology Aeromics, Inc. operates as a preclinical company that develops clinical candidate targeting a molecular water channel for the treatment of cerebral edema (brain swelling) in stroke. It offers AER-271, a drug candidate that blocks aquaporin-4 (AQP4), the molecular water channel found at the blood-brain barrier and controls of cerebral edema in models for ischemic stroke, cardiac arrest, and water toxicity and blocks edema in models of cardiac ischemia and transplant. The company was founded by Marc F. Pelletier and Walter F. Boron in 2008 and is headquartered in Cleveland, OH. | 6 years |
| Mark Day | M | 52 |
Aeromics, Inc.
Aeromics, Inc. BiotechnologyHealth Technology Aeromics, Inc. operates as a preclinical company that develops clinical candidate targeting a molecular water channel for the treatment of cerebral edema (brain swelling) in stroke. It offers AER-271, a drug candidate that blocks aquaporin-4 (AQP4), the molecular water channel found at the blood-brain barrier and controls of cerebral edema in models for ischemic stroke, cardiac arrest, and water toxicity and blocks edema in models of cardiac ischemia and transplant. The company was founded by Marc F. Pelletier and Walter F. Boron in 2008 and is headquartered in Cleveland, OH. | 6 years |
| Suneet Varma | M | 55 | 23 years | |
| François-Maurice Garnier | M | 62 | 21 years | |
| Jack Reynolds | M | - | - | |
| Mark Zhu | M | - | - | |
| Peter C. Agre | M | - |
Aeromics, Inc.
Aeromics, Inc. BiotechnologyHealth Technology Aeromics, Inc. operates as a preclinical company that develops clinical candidate targeting a molecular water channel for the treatment of cerebral edema (brain swelling) in stroke. It offers AER-271, a drug candidate that blocks aquaporin-4 (AQP4), the molecular water channel found at the blood-brain barrier and controls of cerebral edema in models for ischemic stroke, cardiac arrest, and water toxicity and blocks edema in models of cardiac ischemia and transplant. The company was founded by Marc F. Pelletier and Walter F. Boron in 2008 and is headquartered in Cleveland, OH. | 5 years |
| Anthony Caggiano | M | 54 | - | |
| Mohendra Moodley | M | - | - | |
| Peter Longo | M | - |
Aeromics, Inc.
Aeromics, Inc. BiotechnologyHealth Technology Aeromics, Inc. operates as a preclinical company that develops clinical candidate targeting a molecular water channel for the treatment of cerebral edema (brain swelling) in stroke. It offers AER-271, a drug candidate that blocks aquaporin-4 (AQP4), the molecular water channel found at the blood-brain barrier and controls of cerebral edema in models for ischemic stroke, cardiac arrest, and water toxicity and blocks edema in models of cardiac ischemia and transplant. The company was founded by Marc F. Pelletier and Walter F. Boron in 2008 and is headquartered in Cleveland, OH. | 8 years |
| Barbara Dalton | M | 69 | 17 years | |
| Annaliesa Anderson | M | - | 17 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| William Steere | M | 88 | 28 years | |
| Henry McKinnell | M | 81 | 8 years | |
| Jeffrey Kindler | M | 68 | 8 years | |
| Amy Schulman | F | 63 | 6 years | |
| Dennis Ausiello | M | 78 | 13 years | |
| George A. Lorch | M | 82 | 15 years | |
| Constance J. Horner | F | 82 | - | |
| David Shedlarz | M | 75 | 31 years | |
| Alan Levin | M | 62 | 20 years | |
| Martin MacKay | M | 68 | 14 years | |
| Mace Rothenberg | M | 67 | 13 years | |
| Olivier Brandicourt | M | 68 | 13 years | |
| Yi Ning Zhao | M | 53 | 8 years | |
| Paul Fitzhenry | M | 64 | 4 years | |
| Michael R. Jirousek | M | 65 | 5 years | |
| Jonathan Emms | M | - | 20 years | |
| Joseph M. Danis | M | - | 10 years | |
| Mohamed Roushdy | M | - | - | |
| Ranjeev Krishana | M | 50 | 7 years | |
| Everett Cunningham | M | 57 | 9 years | |
| Frank D'Amelio | M | 66 | 14 years | |
| Thomas W. Fry | M | 79 | 3 years | |
| M. Anthony Burns | M | 81 | 25 years | |
| Charles H. Hill | M | 69 | 31 years | |
| Alexandra Kropotova | M | 51 | 5 years | |
| Wyllie Cornwell | M | 76 | 23 years | |
| James Kilts | M | 76 | 13 years | |
| Robert N. Burt | M | 86 | 11 years | |
| George Milne | M | 80 | 32 years | |
| William Herbert Gray | M | 82 | 13 years | |
| Franklin Raines | M | 74 | 11 years | |
| Jennifer Schroeder | F | - | 20 years | |
| Peter Corr | M | 76 | 6 years | |
| Dana George Mead | M | 88 | 12 years | |
| Jacob M. Plotsker | M | 56 | 16 years | |
| Michael Brown | M | 83 | 16 years | |
| Angela Hwang | F | 58 | 26 years | |
| Randy Brenner | M | 51 | 15 years | |
| Joann Eisenhart | M | 65 | 12 years | |
| Daniel Karp | M | 46 | 12 years | |
| Valerie L. Legagneur | F | 50 | 10 years | |
| Robyn Peters | F | - | 4 years | |
| John Borgeson | M | 62 | 21 years | |
| Glenn David | M | 52 | 14 years | |
| David B. Huang | M | 49 | 3 years | |
| Bernard Fermini | M | - | 8 years | |
| Thomas Liquard | M | 51 | 4 years | |
| Anthony Maddaluna | M | 71 | 18 years | |
| Mark Swindell | M | - | 14 years | |
| Loretta Ucelli | F | - | - | |
| Michele A. Gallucci | F | - | 8 years | |
| Scott R. Shively | M | 67 | 3 years | |
| Jennifer J. Rhodes | F | 53 | 6 years | |
| Charles A. Baker | M | 91 | 19 years | |
| Steven Romano | M | 64 | 16 years | |
| Brian R. Krause | M | - | - | |
| Corey Goodman | M | 72 | 2 years | |
| John Young | M | 60 | 14 years | |
| Robert Cohen | M | 66 | 11 years | |
| Tanya Clemons | M | - | - | |
| Marc Stapley | M | 54 | 3 years | |
| Angela Rossetti | F | 71 | 5 years | |
| Craig Eagle | M | 57 | 10 years | |
| David Simmons | M | 59 | 16 years | |
| Anja Guntermann | M | - | 9 years | |
| Julie LeChasseur | F | - | 4 years | |
| Lillian Mu | F | - | 4 years | |
| Michael Pastoor | M | - | 5 years | |
| Anna Berkenblit | M | 54 | 4 years | |
| Louisa Daniels | F | 66 | 13 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Paul R. McGuirk
- Personal Network
